Author: Jartti, Laura; Langen, Henriikka; Söderlund-Venermo, Maria; Vuorinen, Tytti; Ruuskanen, Olli; Jartti, Tuomas
Title: New Respiratory Viruses and the Elderly Document date: 2011_7_6
ID: 7fwzohmu_1
Snippet: Life expectancy has increased globally over the past two centuries by almost 30 years [1] and only over the last five decades by almost 20 years. This very recent phenomenon emerged as a consequence of improvements in nutrition, hygiene, antimicrobial therapy and vaccinations [2, 3] . The development of antiviral therapy, has, however, lagged behind. In the elderly, respiratory viral infections still cause significant morbidity and mortality: up .....
Document: Life expectancy has increased globally over the past two centuries by almost 30 years [1] and only over the last five decades by almost 20 years. This very recent phenomenon emerged as a consequence of improvements in nutrition, hygiene, antimicrobial therapy and vaccinations [2, 3] . The development of antiviral therapy, has, however, lagged behind. In the elderly, respiratory viral infections still cause significant morbidity and mortality: up to 40% of nonpneumonic lower respiratory illnesses have been linked to respiratory viral infection, and in USA alone, an estimated 54,000 annual deaths have been attributed to the influenza and respiratory syncytial viruses (RSV) [4] [5] [6] [7] [8] [9] [10] [11] .
Search related documents:
Co phrase search for related documents- annual death and life expectancy: 1
- annual death and respiratory influenza: 1, 2
- antimicrobial therapy and globally increase: 1
- antimicrobial therapy and life expectancy: 1, 2
- antimicrobial therapy and mortality significant morbidity: 1, 2, 3, 4, 5, 6
- antimicrobial therapy and past century: 1, 2
- antimicrobial therapy and respiratory illness: 1, 2, 3
- antimicrobial therapy and respiratory influenza: 1, 2, 3, 4, 5, 6, 7, 8, 9
- antimicrobial therapy and respiratory influenza syncytial virus: 1, 2, 3
- antimicrobial therapy and respiratory viral infection: 1, 2, 3, 4, 5
- antimicrobial therapy and RSV respiratory influenza syncytial virus: 1, 2
- antiviral therapy and life expectancy: 1, 2
- antiviral therapy and mortality significant morbidity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- antiviral therapy and respiratory illness: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- antiviral therapy and respiratory influenza: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- antiviral therapy and respiratory influenza syncytial virus: 1, 2, 3, 4, 5, 6, 7, 8, 9
- antiviral therapy and respiratory viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- antiviral therapy and RSV respiratory influenza syncytial virus: 1, 2, 3, 4, 5, 6, 7, 8
- antiviral therapy development and RSV respiratory influenza syncytial virus: 1
Co phrase search for related documents, hyperlinks ordered by date